This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maguire, J. H. Articles by Weller, T. H. Search for Related Content PubMed PubMed Citation Articles by Maguire, J. H. Articles by Weller, T. H. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Cardiomyopathy Chagas Disease

Circulation, Vol 75, 1140-1145, Copyright © 1987 by American Heart Association

ARTICLES

Cardiac morbidity and mortality due to Chagas' disease: prospective electrocardiographic study of a Brazilian community

JH Maguire, R Hoff, I Sherlock, AC Guimaraes, AC Sleigh, NB Ramos, KE Mott and TH Weller

The evolution of Chagas' cardiomyopathy is poorly understood. We therefore examined the development of cardiac lesions in a rural Brazilian community for a period of 7 years. Initially, 42% of 1017 residents were seropositive for infection with Trypanosoma cruzi. Age- specific infection rates indicated that most had become infected before the age of 20 years. On follow-up, it appeared that those persons who developed cardiac lesions did so soon after infection, since the incidence of right bundle branch block and other ventricular conduction defects (VCDs) was also highest before age 20 years. The progressive nature of these lesions was demonstrated by frequent development of additional electrocardiographic abnormalities and high mortality among infected adults with VCDs. In contrast, mortality was low and approximately the same for seropositive and seronegative adults under 60 years who had normal electrocardiograms. Electrocardiography during the early asymptomatic stage of infection was able to distinguish persons with potentially lethal cardiac lesions from those with a benign prognosis.

This article has been cited by other articles:

				S. E. Crager and M. Price Prizes and Parasites: Incentive Models for Addressing Chagas Disease J. Law Med. Ethics, June 1, 2009; 37(2): 292 - 304. [PDF]

				C. Bern, S. P. Montgomery, B. L. Herwaldt, A. Rassi Jr, J. A. Marin-Neto, R. O. Dantas, J. H. Maguire, H. Acquatella, C. Morillo, L. V. Kirchhoff, et al. Evaluation and Treatment of Chagas Disease in the United States: A Systematic Review JAMA, November 14, 2007; 298(18): 2171 - 2181. [Abstract] [Full Text] [PDF]

				S. Williams-Blangero, T. Magalhaes, E. Rainwater, J. Blangero, R. Correa-Oliveira, and J. L. VandeBerg Electrocardiographic Characteristics in a Population with High Rates of Seropositivity for Trypanosoma cruzi Infection Am J Trop Med Hyg, September 1, 2007; 77(3): 495 - 499. [Abstract] [Full Text] [PDF]

				A. Rassi Jr, A. Rassi, and S. G. Rassi Predictors of Mortality in Chronic Chagas Disease: A Systematic Review of Observational Studies Circulation, March 6, 2007; 115(9): 1101 - 1108. [Abstract] [Full Text] [PDF]

				H. Acquatella Echocardiography in Chagas Heart Disease Circulation, March 6, 2007; 115(9): 1124 - 1131. [Abstract] [Full Text] [PDF]

				J. H. Maguire Chagas' Disease -- Can We Stop the Deaths? N. Engl. J. Med., August 24, 2006; 355(8): 760 - 761. [Full Text] [PDF]

				A. Rassi Jr., A. Rassi, W. C. Little, S. S. Xavier, S. G. Rassi, A. G. Rassi, G. G. Rassi, A. Hasslocher-Moreno, A. S. Sousa, and M. I. Scanavacca Development and Validation of a Risk Score for Predicting Death in Chagas' Heart Disease N. Engl. J. Med., August 24, 2006; 355(8): 799 - 808. [Abstract] [Full Text] [PDF]

				R. Viotti, C. Vigliano, B. Lococo, G. Bertocchi, M. Petti, M. G. Alvarez, M. Postan, and A. Armenti Long-Term Cardiac Outcomes of Treating Chronic Chagas Disease with Benznidazole versus No Treatment: A Nonrandomized Trial Ann Intern Med, May 16, 2006; 144(10): 724 - 734. [Abstract] [Full Text] [PDF]

				C. E. Rochitte, P. F. Oliveira, J. M. Andrade, B. M. Ianni, J. R. Parga, L. F. Avila, R. Kalil-Filho, C. Mady, J. C. Meneghetti, J. A.C. Lima, et al. Myocardial Delayed Enhancement by Magnetic Resonance Imaging in Patients With Chagas' Disease: A Marker of Disease Severity J. Am. Coll. Cardiol., October 18, 2005; 46(8): 1553 - 1558. [Abstract] [Full Text] [PDF]

				A. G. SCHIJMAN, C. A. VIGLIANO, R. J VIOTTI, J. M. BURGOS, S. BRANDARIZ, B. E. LOCOCO, M. I. LEZE, H. A. ARMENTI, and M. J. LEVIN TRYPANOSOMA CRUZI DNA IN CARDIAC LESIONS OF ARGENTINEAN PATIENTS WITH END-STAGE CHRONIC CHAGAS HEART DISEASE Am J Trop Med Hyg, February 1, 2004; 70(2): 210 - 220. [Abstract] [Full Text] [PDF]

				G. Salles, S. Xavier, A. Sousa, A. Hasslocher-Moreno, and C. Cardoso Prognostic Value of QT Interval Parameters for Mortality Risk Stratification in Chagas' Disease: Results of a Long-Term Follow-Up Study Circulation, July 22, 2003; 108(3): 305 - 312. [Abstract] [Full Text] [PDF]

				M. L. e Costa, S. Barreto, H. Guerra, J. Firmo, E Uchoa, and P. Vidigal Ageing with Trypanosoma cruzi infection in a community where the transmission has been interrupted: the Bambui Health and Ageing Study (BHAS) Int. J. Epidemiol., August 1, 2001; 30(4): 887 - 893. [Abstract] [Full Text] [PDF]

				L. V. Kirchhoff American Trypanosomiasis (Chagas' Disease) -- A Tropical Disease Now in the United States N. Engl. J. Med., August 26, 1993; 329(9): 639 - 644. [Full Text]